Xingchao Shentu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xingchao Shentu has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
Xiaoning Yu
Eye Center, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, P.R. China
18 shared publicationsHao Yang
Zhejiang University, Eye Center of Second Affiliated Hospital, School of Medicine, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou, 310009, China
14 shared publicationsJing Wu
Department of Ophthalmology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, Zhejiang, China; Zhejiang Provincial Key Lab of Ophthalmology, 88 Jiefang Road, Hangzhou, Zhejiang, China; Department of Ophthalmology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, 158 Shangtang Road, Hangzhou, Zhejiang, China
12 shared publicationsXiyuan Ping
Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou310009, China
12 shared publicationsYilei Cui
Eye Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang Provincial Key Laboratory of Ophthalmology, Zhejiang Provincial Clinical Research Center for Eye Diseases, Zhejiang Provincial Engineering Institute on Eye Diseases, Hangzhou310009, China
12 shared publicationsXiajing Tang
The Eye Center, Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China; Zhejiang Provincial Key Lab of Ophthalmology, Hangzhou, Zhejiang Province, China
11 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Elsevier in Materials Today Bio
- Vol. 41
NIR-responsive carbon monoxide nanoplatform for synergistic antibacterial and anti-inflammatory therapy of refractory keratitis and biofilm-infected wounds
- 5 October 2026
- Published by Elsevier in Materials Today Bio
- Vol. 41
Open AccessNIR-responsive carbon monoxide nanoplatform for synergistic antibacterial and anti-inflammatory therapy of refractory keratitis and biofilm-infected wounds
- Open Access
- 8 February 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Zinc peroxide-copper bimetallic nanozyme with self-activated ROS and cuproptosis for superficial antifungal therapy
Fungal infections, particularly intractable cases such as fungal keratitis (FK) and skin wound infections, remain a pressing global health challenge, furth
- 8 February 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessZinc peroxide-copper bimetallic nanozyme with self-activated ROS and cuproptosis for superficial antifungal therapy
Fungal infections, particularly intractable cases such as fungal keratitis (FK) and skin wound infections, remain a pressing global health challenge, furth
- Open Access
- 1 December 2025
- Published by Elsevier in Advances in Ophthalmology Practice and Research
- Vol. 6 (2) , 146-153
Association between red blood cell distribution width to albumin ratio (RAR) and cataract risk: A cross-sectional study from NHANES 1999–2008
- 1 December 2025
- Published by Elsevier in Advances in Ophthalmology Practice and Research
- Vol. 6 (2) , 146-153
Open AccessAssociation between red blood cell distribution width to albumin ratio (RAR) and cataract risk: A cross-sectional study from NHANES 1999–2008
- 7 November 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 388 (Pt 2) , 114394
Multifunctional macrophage membrane biomimetic nanoparticles for targeted therapy of neovascular age-related macular degeneration
- 7 November 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 388 (Pt 2) , 114394
Multifunctional macrophage membrane biomimetic nanoparticles for targeted therapy of neovascular age-related macular degeneration
- Open Access
- 6 November 2025
- Published by Elsevier in Advances in Ophthalmology Practice and Research
- Vol. 6 (1) , 68-79
Advances and challenges of CRISPR/Cas gene editing for corneal diseases
- 6 November 2025
- Published by Elsevier in Advances in Ophthalmology Practice and Research
- Vol. 6 (1) , 68-79
Open AccessAdvances and challenges of CRISPR/Cas gene editing for corneal diseases
- Open Access
- 12 June 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (14)
Enhancing the potency of CAR-T cells against solid tumors through transcription factor engineering
Transcription factors (TFs) play a pivotal role in the development and differentiation of T cells. Recent studies have highlighted unique transcriptional profiles in chimeric antigen receptor T (CAR-T) cells derived from patients with favorable clinical outcomes, suggesting a potential link between TF modulation and improved therapeutic efficacy. Although CAR-T cell therapies have shown some success in treating hematological malignancies, they are limited by challenges such as poor persistence, functional exhaustion, and tumor resistance. To overcome these limitations, researchers have attempted to enhance the efficacy of CAR-T cells through manipulation of TF expression. This Review provides a comprehensive overview of TF engineering in CAR-T cells and elucidates the complex regulatory network between TFs. Notably, modification of basic leucine zipper ATF-like transcription factor in CAR-T cells results in contradictory functional outcomes in different studies. We summarize the potential factors leading to such results and elucidate the importance of setting up a relevant in vitro model to evaluate the effect of TFs on CAR-T cells. In conclusion, this Review highlights the latest advances in TF modifications and proposes strategies for harnessing these insights to empower CAR-T cells with superior antitumor efficacy.
- 12 June 2025
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (14)
Open AccessEnhancing the potency of CAR-T cells against solid tumors through transcription factor engineering
Transcription factors (TFs) play a pivotal role in the development and differentiation of T cells. Recent studies have highlighted unique transcriptional profiles in chimeric antigen receptor T (CAR-T) cells derived from patients with favorable clinical outcomes, suggesting a potential link between TF modulation and improved therapeutic efficacy. Although CAR-T cell therapies have shown some success in treating hematological malignancies, they are limited by challenges such as poor persistence, functional exhaustion, and tumor resistance. To overcome these limitations, researchers have attempted to enhance the efficacy of CAR-T cells through manipulation of TF expression. This Review provides a comprehensive overview of TF engineering in CAR-T cells and elucidates the complex regulatory network between TFs. Notably, modification of basic leucine zipper ATF-like transcription factor in CAR-T cells results in contradictory functional outcomes in different studies. We summarize the potential factors leading to such results and elucidate the importance of setting up a relevant in vitro model to evaluate the effect of TFs on CAR-T cells. In conclusion, this Review highlights the latest advances in TF modifications and proposes strategies for harnessing these insights to empower CAR-T cells with superior antitumor efficacy.
- Open Access
- 19 May 2025
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 51 (1) , 1-13
Postoperative amblyopia in children with congenital cataracts: a systematic review and meta-analysis
This systematic review and meta-analysis aimed to estimate the prevalence of amblyopia following congenital cataract surgery in children and evaluate key prognostic factors, including age at intervention, cataract phenotype, and follow-up duration. We systematically searched PubMed, EMBASE, and the Cochrane Library for studies published between January 1, 1981, and March 1, 2023. We included clinical trials, case series, and observational studies to analyze surgical timing, visual outcomes, and complications. Among 28 studies (2,167 patients, 3,371 eyes), the pooled amblyopia prevalence was 62% (95% CI: 0.55–0.69, I2 = 91.7%). Early surgery (≤ 8 weeks for unilateral, ≤ 12 weeks for bilateral cases) significantly reduced amblyopia risk (P < 0.001) but increased complications, notably glaucoma (26% vs. 6%, P = 0.001). In contrast, intraocular lens (IOL) implantation timing had no significant effect on visual outcomes (P = 0.096). Unilateral partial obstruction conferred a higher amblyopia prevalence than bilateral complete obstruction (68% vs. 36%, P = 0.003), and prolong amblyopia therapy beyond 6 years of age showed limited efficacy. These findings highlight the critical role of timely surgery in optimizing visual recovery, despite its association with complications. Early IOL implantation demonstrated no significant clinical benefits, and the therapeutic window for amblyopia rehabilitation in congenital cataracts is narrower than in other forms.
- 19 May 2025
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 51 (1) , 1-13
Open AccessPostoperative amblyopia in children with congenital cataracts: a systematic review and meta-analysis
This systematic review and meta-analysis aimed to estimate the prevalence of amblyopia following congenital cataract surgery in children and evaluate key prognostic factors, including age at intervention, cataract phenotype, and follow-up duration. We systematically searched PubMed, EMBASE, and the Cochrane Library for studies published between January 1, 1981, and March 1, 2023. We included clinical trials, case series, and observational studies to analyze surgical timing, visual outcomes, and complications. Among 28 studies (2,167 patients, 3,371 eyes), the pooled amblyopia prevalence was 62% (95% CI: 0.55–0.69, I2 = 91.7%). Early surgery (≤ 8 weeks for unilateral, ≤ 12 weeks for bilateral cases) significantly reduced amblyopia risk (P < 0.001) but increased complications, notably glaucoma (26% vs. 6%, P = 0.001). In contrast, intraocular lens (IOL) implantation timing had no significant effect on visual outcomes (P = 0.096). Unilateral partial obstruction conferred a higher amblyopia prevalence than bilateral complete obstruction (68% vs. 36%, P = 0.003), and prolong amblyopia therapy beyond 6 years of age showed limited efficacy. These findings highlight the critical role of timely surgery in optimizing visual recovery, despite its association with complications. Early IOL implantation demonstrated no significant clinical benefits, and the therapeutic window for amblyopia rehabilitation in congenital cataracts is narrower than in other forms.
- 12 April 2025
- Published by Elsevier in Biomaterials
- Vol. 321, 123329
Aminated fullerene for comprehensive dry eye therapy: Promoting epithelial-barrier reconstruction and nerve regeneration by suppressing oxidation and inflammation
- 12 April 2025
- Published by Elsevier in Biomaterials
- Vol. 321, 123329
Aminated fullerene for comprehensive dry eye therapy: Promoting epithelial-barrier reconstruction and nerve regeneration by suppressing oxidation and inflammation
- Open Access
- 8 August 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (18)
Reversible cold-induced lens opacity in a hibernator reveals a molecular target for treating cataracts
Maintaining protein homeostasis (proteostasis) requires precise control of protein folding and degradation. Failure to properly respond to stresses disrupts proteostasis, which is a hallmark of many diseases, including cataracts. Hibernators are natural cold-stress adaptors; however, little is known about how they keep a balanced proteome under conditions of drastic temperature shift. Intriguingly, we identified a reversible lens opacity phenotype in ground squirrels (GSs) associated with their hibernation-rewarming process. To understand this “cataract-reversing” phenomenon, we first established induced lens epithelial cells differentiated from GS-derived induced pluripotent stem cells, which helped us explore the molecular mechanism preventing the accumulation of protein aggregates in GS lenses. We discovered that the ubiquitin-proteasome system (UPS) played a vital role in minimizing the aggregation of the lens protein αA-crystallin (CRYAA) during rewarming. Such function was, for the first time to our knowledge, associated with an E3 ubiquitin ligase, RNF114, which appears to be one of the key mechanisms mediating the turnover and homeostasis of lens proteins. Leveraging this knowledge gained from hibernators, we engineered a deliverable RNF114 complex and successfully reduced lens opacity in rats with cold-induced cataracts and zebrafish with oxidative stress–related cataracts. These data provide new insights into the critical role of the UPS in maintaining proteostasis in cold and possibly other forms of stresses. The newly identified E3 ubiquitin ligase RNF114, related to CRYAA, offers a promising avenue for treating cataracts with protein aggregates.
- 8 August 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (18)
Open AccessReversible cold-induced lens opacity in a hibernator reveals a molecular target for treating cataracts
Maintaining protein homeostasis (proteostasis) requires precise control of protein folding and degradation. Failure to properly respond to stresses disrupts proteostasis, which is a hallmark of many diseases, including cataracts. Hibernators are natural cold-stress adaptors; however, little is known about how they keep a balanced proteome under conditions of drastic temperature shift. Intriguingly, we identified a reversible lens opacity phenotype in ground squirrels (GSs) associated with their hibernation-rewarming process. To understand this “cataract-reversing” phenomenon, we first established induced lens epithelial cells differentiated from GS-derived induced pluripotent stem cells, which helped us explore the molecular mechanism preventing the accumulation of protein aggregates in GS lenses. We discovered that the ubiquitin-proteasome system (UPS) played a vital role in minimizing the aggregation of the lens protein αA-crystallin (CRYAA) during rewarming. Such function was, for the first time to our knowledge, associated with an E3 ubiquitin ligase, RNF114, which appears to be one of the key mechanisms mediating the turnover and homeostasis of lens proteins. Leveraging this knowledge gained from hibernators, we engineered a deliverable RNF114 complex and successfully reduced lens opacity in rats with cold-induced cataracts and zebrafish with oxidative stress–related cataracts. These data provide new insights into the critical role of the UPS in maintaining proteostasis in cold and possibly other forms of stresses. The newly identified E3 ubiquitin ligase RNF114, related to CRYAA, offers a promising avenue for treating cataracts with protein aggregates.